Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in mice

[1]  Zhu Ling,et al.  Inhibition of Schwann cell pannexin 1 attenuates neuropathic pain through the suppression of inflammatory responses , 2022, Journal of Neuroinflammation.

[2]  Y. Ohkawa,et al.  A spinal microglia population involved in remitting and relapsing neuropathic pain , 2022, Science.

[3]  R. Latorre,et al.  Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice , 2022, Nature Communications.

[4]  Han-bing Wang,et al.  Abnormal Insulin-like Growth Factor 1 Signaling Regulates Neuropathic Pain by Mediating the Mechanistic Target of Rapamycin-Related Autophagy and Neuroinflammation in Mice. , 2021, ACS chemical neuroscience.

[5]  B. Schmidt,et al.  Peripheral Nerve Resident Macrophages and Schwann Cells Mediate Cancer-Induced Pain , 2021, Cancer Research.

[6]  R. Ji,et al.  Reciprocal interactions between osteoclasts and nociceptive sensory neurons in bone cancer pain , 2021, Pain reports.

[7]  H. Sadeghnia,et al.  Fibroblast growth factors as tools in management of neuropathic pain disorders. , 2020, Current drug targets.

[8]  Natalie M. Mishina,et al.  Ultrasensitive Genetically Encoded Indicator for Hydrogen Peroxide Identifies Roles for the Oxidant in Cell Migration and Mitochondrial Function. , 2020, Cell metabolism.

[9]  Renzhi Han,et al.  An open-source video tracking system for mouse locomotor activity analysis , 2020, BMC Research Notes.

[10]  Chen Zhang,et al.  An open-source video tracking system for mouse locomotor activity analysis , 2020, BMC Research Notes.

[11]  K. Iwata,et al.  Increase in IGF-1 Expression in the Injured Infraorbital Nerve and Possible Implications for Orofacial Neuropathic Pain , 2019, International journal of molecular sciences.

[12]  W. Leppert,et al.  Bone Pain in Cancer Patients: Mechanisms and Current Treatment , 2019, International journal of molecular sciences.

[13]  N. Bunnett,et al.  Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice. , 2019, The Journal of clinical investigation.

[14]  P. Saunders,et al.  Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  T. Ninomiya,et al.  Establishment and characterization of a C57BL/6 mouse model of bone metastasis of breast cancer , 2019, Journal of Bone and Mineral Metabolism.

[16]  N. Rucci,et al.  Bone Metastasis Pain, from the Bench to the Bedside , 2019, International journal of molecular sciences.

[17]  Zhiqiang Zhang,et al.  Turn-On Fluorescence Probe for Nitric Oxide Detection and Bioimaging in Live Cells and Zebrafish. , 2018, ACS sensors.

[18]  T. Cunha,et al.  Transient receptor potential ankyrin 1 (TRPA1) plays a critical role in a mouse model of cancer pain , 2018, International journal of cancer.

[19]  Yiyun Zhang,et al.  Peripheral pain is enhanced by insulin‐like growth factor 1 and its receptors in a mouse model of type 2 diabetes mellitus , 2018, Journal of diabetes.

[20]  T. Umehara,et al.  IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling , 2018, eLife.

[21]  D. Nosi,et al.  Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice , 2017, Nature Communications.

[22]  N. Brady,et al.  Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions , 2017, PloS one.

[23]  Irina Vetter,et al.  Methods Used to Evaluate Pain Behaviors in Rodents , 2017, Front. Mol. Neurosci..

[24]  J. Nam,et al.  Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis. , 2017, Vaccine.

[25]  M. Jankowski.  A new role of growth hormone and insulin-like growth factor receptor type 1 in neonatal inflammatory nociception: response to commentary , 2017, Pain reports.

[26]  A. Manzano-García,et al.  A new role of growth hormone and insulin growth factor receptor type 1 in neonatal inflammatory nociception , 2017, Pain reports.

[27]  C. Dalgard,et al.  Bone morphogenetic protein-2-mediated pain and inflammation in a rat model of posterolateral arthrodesis , 2016, BMC Neuroscience.

[28]  W. Brenner,et al.  The role of extracellular calcium in bone metastasis , 2016, Journal of bone oncology.

[29]  Zheng Liu,et al.  Interleukin-6: an emerging regulator of pathological pain , 2016, Journal of Neuroinflammation.

[30]  P. Clézardin,et al.  The role of osteoclasts in breast cancer bone metastasis , 2016, Journal of bone oncology.

[31]  J. Bo,et al.  Role of nitric oxide synthase in the development of bone cancer pain and effect of L-NMMA , 2015, Molecular medicine reports.

[32]  John C McGrath,et al.  Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP , 2015, British journal of pharmacology.

[33]  A. Gong,et al.  A fluorescent probe for hypochlorite based on the modulation of the unique rotation of the N-N single bond in acetohydrazide. , 2015, Chemical communications.

[34]  Y. Zhang,et al.  Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein–mediated stimulation of T-type calcium channels , 2014, Science Signaling.

[35]  D. Shaw,et al.  How IGF-1 activates its receptor , 2014, eLife.

[36]  J. Lennerz,et al.  H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO–TRPA1–CGRP signalling pathway , 2014, Nature Communications.

[37]  Y. Li,et al.  Enhanced function of TRPV1 via up‐regulation by insulin‐like growth factor‐1 in a rat model of bone cancer pain , 2014, European journal of pain.

[38]  P. Mantyh.  Bone cancer pain: from mechanism to therapy , 2014, Current opinion in supportive and palliative care.

[39]  A. Rice,et al.  A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy , 2013, PAIN.

[40]  A. Rossary,et al.  Effects of Enriched Environment on COX-2, Leptin and Eicosanoids in a Mouse Model of Breast Cancer , 2012, PloS one.

[41]  T. Yoneda,et al.  Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases. , 2012, Cancer research.

[42]  T. Guise,et al.  Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.

[43]  F. Amaya,et al.  Peripheral sensitization caused by insulin-like growth factor 1 contributes to pain hypersensitivity after tissue injury , 2011, PAIN®.

[44]  M. Sekiguchi,et al.  Localization and Function of Insulin-like Growth Factor 1 in Dorsal Root Ganglia in a Rat Disc Herniation Model , 2011, Spine.

[45]  M. Al Banchaabouchi,et al.  Generation and characterization of an Advillin-Cre driver mouse line , 2011, Molecular pain.

[46]  Yu-Chi Chen,et al.  Breast cancer metastasis to the bone: mechanisms of bone loss , 2010, Breast Cancer Research.

[47]  Y. DeClerck,et al.  Interleukin-6 in bone metastasis and cancer progression. , 2010, European journal of cancer.

[48]  D. Rades,et al.  Treatment of painful bone metastases , 2010, Nature Reviews Clinical Oncology.

[49]  Zhong-Wei Zhang,et al.  Transforming growth factor-β1 impairs neuropathic pain through pleiotropic effects , 2009, Molecular pain.

[50]  K. Miyazono,et al.  Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway , 2008, Oncogene.

[51]  F. Hassan,et al.  Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells. , 2007, Biochemical and biophysical research communications.

[52]  Edgar Erdfelder,et al.  G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.

[53]  Dirk Hadaschik,et al.  Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. , 2007, The Biochemical journal.

[54]  M. Etienne,et al.  Acetaminophen Recruits Spinal p42/p44 MAPKs and GH/IGF-1 Receptors to Produce Analgesia via the Serotonergic System , 2007, Molecular Pharmacology.

[55]  P. Mantyh.  The science behind metastatic bone pain , 2006 .

[56]  Clifford J. Woolf,et al.  TRPA1 Contributes to Cold, Mechanical, and Chemical Nociception but Is Not Essential for Hair-Cell Transduction , 2006, Neuron.

[57]  M. J. Ehrke,et al.  Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. , 2005, Anticancer research.

[58]  K. Lau,et al.  An osteoclastic protein-tyrosine phosphatase may play a role in differentiation and activity of human monocytic U-937 cell-derived, osteoclast-like cells. , 2004, American journal of physiology. Cell physiology.

[59]  Jiayou Zhang,et al.  Conditional macrophage ablation in transgenic mice expressing a Fas‐based suicide gene , 2004, Journal of leukocyte biology.

[60]  M. Seibel,et al.  Markers of Bone Remodeling in Metastatic Bone Disease , 2003 .

[61]  A. Hoeflich,et al.  IGF-binding protein-4: biochemical characteristics and functional consequences. , 2003, The Journal of endocrinology.

[62]  P. Chambon,et al.  A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse , 2003, Nature Biotechnology.

[63]  T. O'reilly,et al.  A rat model of bone cancer pain , 2002, Pain.

[64]  T. Guise.  Molecular mechanisms of osteolytic bone metastases , 2000, Cancer.

[65]  T. Kilpatrick,et al.  A Role for Insulin-Like Growth Factor-I in the Regulation of Schwann Cell Survival , 1999, The Journal of Neuroscience.

[66]  M. Bitar,et al.  Antinociceptive action of intrathecally administered IGF-I and the expression of its receptor in rat spinal cord , 1996, Brain Research.

[67]  S. Mohan,et al.  Studies on the Mechanisms by Which Insulin-like Growth Factor (IGF) Binding Protein-4 (IGFBP-4) and IGFBP-5 Modulate IGF Actions in Bone Cells (*) , 1995, The Journal of Biological Chemistry.

[68]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[69]  S. Mohan,et al.  Insulin‐like growth factor binding protein–4 inhibits both basal and IGF‐mediated chick pelvic cartilage growth in vitro , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[70]  G. Nicolson,et al.  Specificity of arrest, survival, and growth of selected metastatic variant cell lines. , 1978, Cancer research.

[71]  R. Abrams,et al.  Improving the Quality of Life. , 1971 .

[72]  A. Paller,et al.  Flotillin and AP2A1/2 Promote IGF-1 Receptor Association with Clathrin and Internalization in Primary Human Keratinocytes , 2020 .

[73]  Haesun A Kim,et al.  Schwann Cells , 2018, Methods in Molecular Biology.

[74]  D. Santini,et al.  Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain. , 2017, European journal of cancer.

[75]  J. Brown,et al.  localization and function. , 2014 .

[76]  Y. Li,et al.  Enhanced function of TRPV 1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain , 2013 .

[77]  M. Seibel,et al.  Clinical review 165: Markers of bone remodeling in metastatic bone disease. , 2003, The Journal of clinical endocrinology and metabolism.

[78]  M. Roth.  A quantitative assessment , 1987 .